Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Practical points for applying herpes zoster vaccine recommendations.

Brogie JD, Rumph JH, Chaplin MD, Drake N, Hodge BK, Owens RE.

Nurse Pract. 2019 Sep;44(9):43-47. doi: 10.1097/01.NPR.0000574676.64980.7e.

PMID:
31436592
2.

Application of a correlation correction factor in a microarray cross-platform reproducibility study.

Archer KJ, Dumur CI, Taylor GS, Chaplin MD, Guiseppi-Elie A, Grant G, Ferreira-Gonzalez A, Garrett CT.

BMC Bioinformatics. 2007 Nov 15;8:447.

3.

A disattenuated correlation estimate when variables are measured with error: illustration estimating cross-platform correlations.

Archer KJ, Dumur CI, Taylor GS, Chaplin MD, Guiseppi-Elie A, Buck GA, Grant G, Ferreira-Gonzalez A, Garrett CT.

Stat Med. 2008 Mar 30;27(7):1026-39.

PMID:
17600855
4.

Genome of the opportunistic pathogen Streptococcus sanguinis.

Xu P, Alves JM, Kitten T, Brown A, Chen Z, Ozaki LS, Manque P, Ge X, Serrano MG, Puiu D, Hendricks S, Wang Y, Chaplin MD, Akan D, Paik S, Peterson DL, Macrina FL, Buck GA.

J Bacteriol. 2007 Apr;189(8):3166-75. Epub 2007 Feb 2.

5.

Pharmacokinetics and bioavailability of N-tert-butyl-alpha-phenyl nitrone in rats and dogs.

Chan TY, Privat SJ, Narducy KW, Chaplin MD, Waterbury LD.

Proc West Pharmacol Soc. 1997;40:57-9. No abstract available.

PMID:
9436213
6.

Bioavailability of nafarelin in healthy volunteers.

Chaplin MD.

Am J Obstet Gynecol. 1992 Feb;166(2):762-5.

PMID:
1531580
7.

Absorption and metabolism of nafarelin, a potent agonist of gonadotropin-releasing hormone.

Chan RL, Henzl MR, LePage ME, LaFargue J, Nerenberg CA, Anik S, Chaplin MD.

Clin Pharmacol Ther. 1988 Sep;44(3):275-82.

PMID:
2970910
8.

Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function.

Sommadossi JP, Bevan R, Ling T, Lee F, Mastre B, Chaplin MD, Nerenberg C, Koretz S, Buhles WC Jr.

Rev Infect Dis. 1988 Jul-Aug;10 Suppl 3:S507-14.

PMID:
2847287
9.

Inhibition and induction of hepatic drug metabolism in rats and mice by nafimidone and its major metabolite nafimidone alcohol.

Rush WR, Smith SA, Mulvey JH, Graham DJ, Chaplin MD.

Drug Metab Dispos. 1987 Jul-Aug;15(4):571-8.

PMID:
2888633
10.

Disposition of nafimidone in rats.

Graham DJ, Hama KM, Smith SA, Kurz L, Chaplin MD, Hall DJ.

Drug Metab Dispos. 1987 Jul-Aug;15(4):565-70.

PMID:
2888632
11.

Clinical development of nafarelin acetate. Phase I and phase II studies.

Hoffman PG, Henzl MR, Chaplin MD, Nerenberg CA.

J Androl. 1987 Jan-Feb;8(1):S17-22. No abstract available.

13.

Disposition of nafarelin acetate, a potent agonist of luteinizing hormone-releasing hormone, in rats and rhesus monkeys.

Chu NI, Chan RL, Hama KM, Chaplin MD.

Drug Metab Dispos. 1985 Sep-Oct;13(5):560-5.

PMID:
2865103
14.

Plasma binding of LHRH and nafarelin acetate, a highly potent LHRH agonist.

Chan RL, Chaplin MD.

Biochem Biophys Res Commun. 1985 Mar 15;127(2):673-9.

PMID:
3156598
15.

Radioimmunoassay of nafarelin ([ 6-(3-(2-naphthyl)-D-alanine)]-luteinizing hormone-releasing hormone) in plasma or serum.

Nerenberg C, Foreman J, Chu N, Chaplin MD, Kushinsky S.

Anal Biochem. 1984 Aug 15;141(1):10-6.

PMID:
6238549
16.

Comparative disposition of nafarelin and endogenous luteinizing hormone releasing hormone in female rats.

Hama KM, Chu NI, Chan RL, Chaplin MD.

Proc West Pharmacol Soc. 1984;27:303-6. No abstract available.

PMID:
6238335
17.

Species variation in percutaneous absorption of sulconazole nitrate, a new anti-fungal agent.

Zaro BA, Hama KM, Chaplin MD.

Proc West Pharmacol Soc. 1982;25:357-9. No abstract available.

PMID:
7122521
18.

In vitro studies on the binding of cloprednol to human plasma proteins.

Tomlinson RV, Runkel R, Chaplin MD, Bowen L, Kanagy J, Chu N.

J Steroid Biochem. 1982 Jan;16(1):75-80. No abstract available.

PMID:
7062742
19.

Isolation and identification of an oxidatively defluorinated metabolite of flunisolide in man.

Tökés L, Cho D, Maddox ML, Chaplin MD, Chu NI.

Drug Metab Dispos. 1981 Sep-Oct;9(5):485-6. No abstract available.

PMID:
6117452
20.

Mechanism for the oxidative defluorination of flunisolide.

Teitelbaum PJ, Chu NI, Cho D, Tökés L, Patterson JW, Wagner PJ, Chaplin MD.

J Pharmacol Exp Ther. 1981 Jul;218(1):16-22.

PMID:
7241375
21.

Apparent sex difference in the metabolism of flunisolide in rats.

Chaplin MD, Hama KM, Chu NI.

Proc West Pharmacol Soc. 1981;24:285-7. No abstract available.

PMID:
7255470
22.

A HPLC radiometric assay to quantitate flunisolide metabolites in body fluids.

Chu NI, Teitelbaum PJ, Chaplin MD.

Proc West Pharmacol Soc. 1981;24:281-4. No abstract available.

PMID:
7255469
23.

Correlation of flunisolide plasma levels to eosinopenic response in humans.

Chaplin MD, Cooper WC, Segre EJ, Oren J, Jones RE, Nerenberg C.

J Allergy Clin Immunol. 1980 Jun;65(6):445-453. No abstract available.

PMID:
7372965
24.

Flunisolide metabolism and dynamics of a metabolite.

Chaplin MD, Rooks W 2nd, Swenson EW, Cooper WC, Nerenberg C, Chu NI.

Clin Pharmacol Ther. 1980 Mar;27(3):402-13.

PMID:
7357797
25.

Disposition of flunisolide in the rat, mouse, dog, rhesus monkey, and cynomolgus monkey.

Chu NI, Amos BA, Tökés L, Maddox ML, Matin SB, Hama KM, Patterson JW, Wagner PJ, Bell JP, Chaplin MD.

Drug Metab Dispos. 1979 Mar-Apr;7(2):81-9.

PMID:
38078
26.

Pharmacokinetics of naproxen overdoses.

Runkel R, Chaplin MD, Sevelius H, Ortega E, Segre E.

Clin Pharmacol Ther. 1976 Sep;20(3):269-77.

PMID:
954349
27.

Effect of repeated dosing with aspirin on plasma levels of naproxen (D-2-(6'-methoxy-2'-naphthyl)-propionic acid) in rats.

Chaplin MD, Chu NI, Rice BG, Hama KM.

Proc West Pharmacol Soc. 1975;18:62-6. No abstract available.

PMID:
1182041
28.

Sex-dependent differences in drug metabolism in the rat. IV. Effect of morphine administration.

Sladek NE, Chaplin MD, Mannering GJ.

Drug Metab Dispos. 1974 May-Jun;2(3):293-300. No abstract available.

PMID:
4153060
29.

Lowering of plasma concentrations of (+)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid (naproxen) by aspirin in rats.

Chaplin MD.

Biochem Pharmacol. 1973 Jul 1;22(13):1589-98. No abstract available.

PMID:
4729806
30.

Displacement of thiopental from plasma proteins by nonsteroidal anti-inflammatory agents.

Chaplin MD, Roszkowski AP, Richards RK.

Proc Soc Exp Biol Med. 1973 Jul;143(3):667-71. No abstract available.

PMID:
4719452
31.

Role of phospholipids in the hepatic microsomal drug-metabolizing system.

Chaplin MD, Mannering GJ.

Mol Pharmacol. 1970 Nov;6(6):631-40. No abstract available.

PMID:
5497715
32.

Induction of drug metabolism. 3. Further information of a new P-450 hemoprotein after treatment of rats with 3-methylcholanthrene.

Shoeman DW, Chaplin MD, Mannering GJ.

Mol Pharmacol. 1969 Jul;5(4):412-9. No abstract available.

PMID:
5803388
33.

Amino alcohols and methyl donors in rats fed low choline diets containing added cholesterol.

Chaplin MD, Mulford DJ.

J Nutr. 1966 Aug;89(4):501-4. No abstract available.

PMID:
5916421

Supplemental Content

Loading ...
Support Center